Clinical trial
Genetic Susceptibility to Oncogenic Viruses
NCT00341484 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00341484 |
|---|---|
| Title | Genetic Susceptibility to Oncogenic Viruses |
| Official title | Genetic Susceptibility to Oncogenic Viruses |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Liver Neoplasms, HIV Infections |
| Enrollment | 2,580 |
| Start date | Jun 1, 1998 |
| Primary completion | Jun 5, 2007 |
| Completion | Jun 5, 2007 |
| First posted | Jun 21, 2006 |
| Last update posted | Jun 16, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: